...
首页> 外文期刊>Public health genomics >Patient perspectives on group benefits and harms in genetic research
【24h】

Patient perspectives on group benefits and harms in genetic research

机译:患者对基因研究中团体利益和伤害的看法

获取原文
获取原文并翻译 | 示例
           

摘要

It is unclear how the possible effects of genetic research on socially identifiable groups may impact patient willingness to donate biological samples for future genetic studies. Methods: Telephone interviews with patients at 5 academic medical centers in the U.S. examined how patients' beliefs about benefits and harms to ones racial or ethnic group shape decisions to participate in genetic research. Results: Of the 1,113 patients who responded to questions about group harms and benefits, 61% of respondents indicated that potential benefits to their own racial or ethnic group would be a big or moderate part of their decision to donate a sample for genetic research. 63% of black respondents and 57% of white respondents indicated that they were 'very' or 'moderately concerned' about genetic research findings being used to discriminate against people by race or ethnicity. 64% of black and 34% of white respondents reported that their willingness to donate a blood sample would be substantially reduced due to these concerns. Conclusion: Our findings suggest that a key factor in many patients' decisions to donate samples for genetic research is how those studies may impact identifiable racial and ethnic groups. Given the importance of these considerations to many patients, our study highlights a need to address patients' concerns about potential group benefits and harms in the design of future research studies and DNA biobanks.
机译:尚不清楚基因研究对社会可识别群体的可能影响如何影响患者捐赠生物样本用于未来基因研究的意愿。方法:在美国5个学术医学中心对患者进行电话采访,考察了患者对种族或族裔利益的看法如何影响参与基因研究的决定。结果:在回答有关群体伤害和利益问题的1,113名患者中,有61%的受访者表示,对自己的种族或族裔群体的潜在利益将是他们决定捐赠样本进行基因研究的很大或中等的一部分。 63%的黑人受访者和57%的白人受访者表示,他们“非常”或“中等程度地关注”遗传研究发现被用于按种族或族裔歧视人。 64%的黑人和34%的白人受访者表示,由于这些担忧,他们捐献血液样本的意愿将大大降低。结论:我们的发现表明,许多患者决定为基因研究捐赠样本的关键因素是这些研究如何影响可识别的种族和族裔群体。考虑到这些考虑因素对许多患者的重要性,我们的研究强调在设计未来的研究和DNA生物库时,需要解决患者对潜在的群体利益和危害的担忧。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号